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Abstract
Motivated by linkage data and the hypothesis that angiogenesis
plays a functional role in rheumatoid arthritis (RA), Jacq and
colleagues present a family-based, multi-stage, candidate gene
association study in French and European Caucasians in a paper
on the association of the ITGAV rs3738919-C variant allele with
RA (C-containing genotypes: odds ratio 1.94, confidence interval
1.3 to 2.9, P = 0.002). Support comes from a recent genome-wide
study, which on its own would have missed identifying the
association. Further research into the associating variant will
require detailed haplotype analysis, verification in further studies,
and research involving intermediate phenotypes or direct functional
experiments. This new RA risk factor supports the role of
angiogenesis in the disease.
Jacq and colleagues [1] have presented a candidate gene
association study in French and European Caucasian
populations, showing evidence that the rs3738919-C variant
(major allele) of the gene ITGAV may be associated with
rheumatoid arthritis (RA), with an overall odds ratio (OR) for
C-containing genotypes of 1.94 and a 95% confidence
interval (CI) of 1.3 to 2.9 (P = 0.002). In the light of difficulties
surrounding studies on candidate gene associations, how did
the authors arrive at this result, what needs to be done
further, and how does the discovery fit in the quest for solving
RA genetics?
ITGAV was selected as a candidate gene for RA for two
reasons. First, it is localized 194 centimorgans from the p-
telomere of chromosome 2, within a region stretching from
193 to 202 centimorgans that has been implicated by an RA
genome scan [2]. Second, there is a strong functional
hypothesis: ITGAV encodes the protein αv (CD51 antigen) of
the integrin family, which combines with β3 to form the
vitronectin receptor [3] and has a central role in angiogenesis
[4]. Angiogenesis, in turn, is involved in hyperplasia of the
synovial membrane in the RA pannus [5]. Modulation of
angiogenesis by ITGAV variants is supported by the
association of ITGAV with priapism [6].
The genomic region of ITGAV does not show any apparent
functional implication of rs3738919. However, some SNPs
are predicted to be located inside functional elements of
ITGAV and part of the region seems to show variation in copy
number. It is possible that rs3738919 reports on these
polymorphisms as a result of linkage disequilibrium. Without
haplotype analyses and functional studies it remains unknown
whether rs3738919 is itself a disease-modifying variant or
whether it is a signpost for a causative variant that has yet to
be discovered. Identification of the causative variant, or of a
comprehensive haplotype carrying it, would greatly facilitate
replication studies needed to verify this new association.
In their candidate gene association study, Jacq and
colleagues employed a family-based, multistage design. The
use of patients and their parents inherently avoids problems
with unknown population stratification. For the alternative
case-control design, identifying stratifications requires the
typing of many markers and extensive data analysis [7] and is
therefore especially suitable for genome-wide studies [8].
In the first stage of a multistage study, associating markers
and initial genetic models are identified without correction for
multiple testing. ITGAV rs3738919-C association was found
with an allelic OR of 1.5 and a significant increase in the C/C
genotype. Further stages are to refine genetic models and to
weed out false positives that may occur as a result of random
differences in allele frequency in smaller cohorts or inhomo-
geneous phenotypes. For complex, heterogeneous diseases
such as RA, even clinically very similar patients may represent
pathomechanistically different disease subtypes not always
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discernible by current scores and laboratory parameters. If a
genetic variant is relevant in only some subtypes (defined by
sex, erosion status, auto-antibodies, or other parameters), its
effect may be present in one cohort but not in another and
may appear with smaller effect size in large, multi-center
cohorts.
In a recent hypothesis-free, genome-wide association study
for RA in a British population [8], rs3738919 was imputed
from surrounding genotypes. Association of rs3738919-C
did not emerge with genome-wide significance. However, the
test of the single hypothesis of association of rs3738919-C
with RA is significant (allelic OR 1.12, CI 1.02 to 1.22,
P = 0.01). In comparison, from the data by Jacq and
colleagues an allelic OR of 1.3 (CI 1.06 to 1.59, P = 0.01)
can be calculated. Joint analysis of both studies results in an
allelic OR of 1.14 (CI 1.06 to 1.24, P = 0.001; Mantel–
Haenszel test, fixed effects [9]). This strongly supports a
common role of ITGAV in RA, at least for populations with
European ancestries. It also shows that both genome-wide
studies and candidate gene studies will be important in the
ongoing quest to identify genetic factors in complex diseases
such as RA.
Association of HLA-DRB1 alleles and PTPN22 alleles with
RA are well established [8,10,11]. For other potential RA loci,
reported effects are usually small and replication studies
were inconclusive. Notably, one well-powered candidate
gene study in a Caucasian population verified associations
between PADI4 and CTLA4, but not with other associations
[12]. With OR in the range 1.1 to 1.2, variants of PADI4 and
CTLA4 confer a similar risk to that of the new ITGAV variant.
Because confirmed associations account for only about 50%
of RA genetics, more candidate loci conferring similar risks
are to be expected. They will probably be found on the basis
of functional insights, computational modeling, animal
models, expression analysis, and genome-wide association
studies. Verification of newly found associations would be
greatly aided by the deposition of genotypes and detailed
phenotype data in public databases such as dbGaP [13] for
use in (disease sub-type-specific) meta-analyses.
ITGAV is the latest example of a candidate gene that may be
relevant to RA. Increased significance in the combined
samples in the study of Jacq and colleagues, corroborated by
data from a genome-wide study, suggests that this
association may indeed be true and common to different
European ancestries. Further research into the associating
variant will require detailed haplotype analysis, verification in
further studies, and research involving intermediate pheno-
types or direct functional experiments. The newly found gene
variant may not provide utility as a diagnostic marker for RA
because of its high frequency in healthy controls. However, it
may be another important step on the way to a better
understanding of RA etiology and pathomechanisms, in
particular the role of angiogenesis.
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
The authors thank Markus Scholz for helpful discussion of the manu-
script, and the Wellcome Trust Case Control Consortium for access to
data from the genome-wide study on RA.
References
1. Jacq L, Garnier S, Dieude P, Michou L, Pierlot C, Migliorini P,
Balsa A, Westhovens R, Barrera P, Alves H, et al.: The ITGAV
rs3738919-C allele is associated with rheumatoid arthritis in
the European Caucasian population: a family-based study.
Arthritis Res Ther 2007, 9:R63.
2. Osorio YF, Bukulmez H, Petit-Teixeira E, Michou L, Pierlot C, Cail-
leau-Moindrault S, Lemaire I, Lasbleiz S, Alibert O, Quillet P, et al.:
Dense genome-wide linkage analysis of rheumatoid arthritis,
including covariates. Arthritis Rheum 2004, 50:2757-2765.
3. Horton MA: The  α αv β β3 integrin ‘vitronectin receptor’. Int J
Biochem Cell Biol 1997, 29:721-725.
4. Ruegg C, Mariotti A: Vascular integrins: pleiotropic adhesion
and signaling molecules in vascular homeostasis and angio-
genesis. Cell Mol Life Sci 2003, 60:1135-1157.
5. Koch AE, Distler O: Vasculopathy and disordered angiogene-
sis in selected rheumatic diseases: rheumatoid arthritis and
systemic sclerosis. Arthritis Res Ther 2007, 9(Suppl 2):S3.
6. Elliott L, Ashley-Koch AE, De Castro L, Jonassaint J, Price J, Ataga
KI, Levesque MC, Brice WJ, Eckman JR, Orringer EP, et al.:
Genetic polymorphisms associated with priapism in sickle
cell disease. Br J Haematol 2007, 137:262-267.
7. Pritchard JK, Rosenberg NA: Use of unlinked genetic markers
to detect population stratification in association studies. Am J
Hum Genet 1999, 65:220-228.
8. The Wellcome Trust Case Control Consortium: Genome-wide
association study of 14,000 cases of seven common diseases
and 3,000 shared controls. Nature 2007, 447:661-678.
9. Mantel N, Haenszel W: Statistical aspects of the analysis of
data from retrospective studies of disease. J Natl Cancer Inst
1959, 22:719-748.
10. de Vries RR, Huizinga TW, Toes RE: Redefining the HLA and RA
association: to be or not to be anti-CCP positive. J Autoimmun
2005, 25(Suppl):21-25.
11. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, Harley JB:
The PTPN22 C1858T functional polymorphism and autoim-
mune diseases – a meta-analysis. Rheumatology (Oxford)
2007, 46:49-56.
12. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson
EW, Wolfe F, Kastner DL, Alfredsson L, Altshuler D, et al.: Repli-
cation of putative candidate-gene associations with rheuma-
toid arthritis in >4,000 samples from North America and
Sweden: association of susceptibility with PTPN22, CTLA4,
and PADI4. Am J Hum Genet 2005, 77:1044-1060.
13. dbGaP [http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap]